Trials that matter: Two faces of progress in the treatment of age-related macular degeneration

被引：7
作者：
Epstein, Paul [1 ]
机构：
[1] Amer Coll Physicians, Customer Serv, Philadelphia, PA 19106 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2007年 / 146卷 / 07期
关键词：
D O I：
10.7326/0003-4819-146-7-200704030-00011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：532 / 534
页数：3
相关论文
共 5 条
[1]   Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration [J].
Avery, RL ;
Pieramici, DJ ;
Rabena, MD ;
Castellarin, AA ;
Nasir, MA ;
Giust, MJ .
OPHTHALMOLOGY, 2006, 113 (03) :363-372
[2]   Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy [J].
Avery, Robert L. ;
Pearlman, Joel ;
Pieramici, Dante J. ;
Rabena, Melvin D. ;
Castellarin, Alessandro A. ;
Nasir, Ma'an A. ;
Giust, Matthew J. ;
Wendel, Robert ;
Patel, Arun .
OPHTHALMOLOGY, 2006, 113 (10) :1695-1705
[3]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[4]   Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration - Twelve-week results of an uncontrolled open-label clinical study [J].
Michels, S ;
Rosenfeld, PJ ;
Puliafito, CA ;
Marcus, EN ;
Venkatraman, AS .
OPHTHALMOLOGY, 2005, 112 (06) :1035-1047
[5]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
1